References
- Kurzrock R., Talpaz M., Gomez J.A., Estey E.H., O'Brien S., Hirsch Ginsberg C., Koller C., Freireich E.J., Gutterman J.U. Differential dose-related haematological effects of GM-CSF in pancytopenia: evidence supporting the advantage of low- over high-dose administration in selected patients. Br J Haematol 1991; 78(3)352–8
- Hollander A.A., Kluin Nelemans H.C., Haak H.R., Stern A.C., Willemze R., Fibbe W.E. Correction of neutropenia associated with chronic lymphocytic leukaemia following treatment with granulocyte-macrophage colony-stimulating factor. Ann Hematol 1991; 62(1)32–4
- Vadhan-Raj S., Velasquez W.S., Butler J.J., LeMaistre A., Lepe Zuniga J., Keating M.J., Koller C.A., Gutterman J.U. Stimulation of myelopoiesis in chronic lymphocytic leukemia and in other lymphoproliferative disorders by recombinant human granulocyte-macrophage colony-stimulating factor. Am J Hematol 1990; 33(3)189–97
- Itala M., Pelliniemi T.T., Remes K. GM-CSF raises serum levels of beta 2-microglobulin and thymidine kinase in patients with chronic lymphocytic leukaemia. Br J Haematol 1996; 94(1)129–32
- Sarris A.H., Majlis A., Dimopoulos M.A., Younes A., Swann F., Rodriguez M.A., McLaughlin P., Cabanillas F. Rising serum lactate dehydrogenase often caused by granulocyte-or Granulocyte-macrophage colony stimulating factor and not tumor progression in patients with lymphoma or myeloma. Leuk Lymphoma 1995; 17(5–6)473–7
- Rozman C., Montserrat E. Chronic lymphocytic leukemia. N Engl J Med 1995; 333(16)1052–7
- Jurlander J., Geisler C.H., Hansen M.M. Treatment of hypogammaglobulinaemia in chronic lymphocytic leukaemia by low-dose intravenous gammaglobulin. Eur J Haematol 1994; 53(2)114–8